Navigation Links
Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
Date:3/12/2009

WASHINGTON, March 12 /PRNewswire-FirstCall/ -- Proposed legislation that creates a regulatory framework to guide the approval of the first biogeneric medicines represents a critical step forward in providing more affordable treatment for millions of Americans suffering from chronic and complex conditions, David B. Snow Jr., chairman and CEO of Medco Health Solutions, Inc. (NYSE: MHS) said today.

"The investment in research and innovation over a period of many years has led to the breakthrough therapies that are available today in specialty pharmacy for the treatment of many serious diseases," said Snow. "We salute the vision of Chairman Waxman, Representative Deal and their co-sponsors, who have crafted an approach that balances the government's role for promulgating and regulating, while allowing the private sector to innovate and operate. This framework authorizes the FDA to construct an approval process that can lead to lower costs for payors and patients, while continuing to incent and reward breakthrough science."

Currently, as much as 16 percent of overall spending on so-called "specialty" medicines goes toward purchasing biotech drugs that have already lost their patent protection but, without this critical approval process, have no lower-cost generic competition. Medco estimates that generic versions of biotech medicines -- often called "biosimilars"-- could reach the market by 2013, creating a $34 billion opportunity in this new market through 2017, and significantly lowering the costs for these medicines.

"This legislation provides the FDA with the authority to ensure that we remain the world's gold standard for prescription drug safety, and extends it to a generics approval process for a new class of medicines," said Snow. "For all their therapeutic benefit, patients and payors alike are overwhelmed
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
2. Hospira Supports Newly Introduced Biogenerics Legislation
3. CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
4. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
5. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
6. Biogenerics Will Save Billions, Says Hospira CEO
7. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
8. Teva Applauds Historic Biotech Competition Legislation
9. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing and the Importance of New Medicare-Related E-Prescribing Legislation
10. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
11. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 On 25-28 July, 2013, ... in Paris - the beautiful city of lights. , ... Medicine is revolutionizing the medical world. Understanding and integrating ... the hallmark of this transformation. Much of the present ... the epidemiologic studies of large cohorts that do not ...
(Date:5/20/2013)... Kitware, a leader in data visualization, ... the exploration of hospital costs across the United ... the recent release of “Medicare Provider Charge Data,” a ... procedures from the Centers for Medicare & Medicaid Services. ... at hospitals across the country has sparked considerable controversy; ...
(Date:5/20/2013)... May 20, 2013 In Early 2013, ... field of biotoxin related illnesses , announced his vision ... able to advance his protocol for treating Chronic Inflammatory ... the third physician to achieve certification in the Shoemaker ... able to practice the Shoemaker Protocol in other parts ...
(Date:5/20/2013)... City, CA (PRWEB) May 20, 2013 ... has announced the appointment of Lisa Baird as Executive ... on July 8, 2013. The WMIS vision ... imaging applications to understand and effectively treat diseases in ... Imaging Society (WMIS) was established in 2011 by integrating ...
Breaking Biology Technology:The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2WMIS Appoints Lisa Baird as Next Executive Director 2
... , COLUMBIA, Md., Sept. 2 ACell, ... Global Investment Conference. , , The conference ... the New York Palace Hotel in New York City. James DeFrancesco, ... presentation on September 11th beginning at 9:10 AM (EDT) in the ...
... , HAYWARD, Calif., Sept. 2 ... completed the second closing of its Series A equity financing ... round to $5.4 million. , , ACD ... proprietary diagnostic tests based on the company,s patent pending RNAscope(TM) ...
... , , , INDIANAPOLIS, ... company, today announced that, effective October 1, 2009, it would ... cents per kg for all non-contract customers or as existing ... continue to invest in expanding global supply for the high ...
Cached Biology Technology:ACell's CEO to Present at Rodman & Renshaw's 2009 Annual Global Investment Conference 2ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development 2
(Date:5/16/2013)... predict the stability of today,s largest ice sheets in Greenland ... years ago, for example when Earth was going through ... a high sea level due to ice sheet collapse at ... that if the world,s largest ice sheets collapsed in the ... modern, progressively warming world. , However, a new groundbreaking ...
(Date:5/16/2013)... Why do so many sports players and athletes choose ... new study to be published in Psychological Science ... suggests that it may have to do with their ... scientist Daniel Farrelly of the University of Sunderland and ... color in a competitive task had higher testosterone levels ...
(Date:5/16/2013)... (GWA), where the entirety of an individual,s DNA is ... which can cause health problems is a massively useful ... pose major ethical problems if used incorrectly, say new ... published on line today (16 May 2013) in the ... based on whole genome and on exome* sequencing and ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2High-testosterone competitors more likely to choose red 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
... Capuchin monkeys are playful, inquisitive primates known for their ... New research now shows that just like humans, they ... the brain, specifically in the corpus callosum, the region ... A recently published paper by Associate Professor of Psychology ...
... hepatitis C virus (HCV). The outcome of HCV infections is ... chronic infections will develop into liver cirrhosis or liver cancer. ... is there any approved vaccine for this virus, hepatitis C ... fifty percent of HCV infected patients recovers spontaneously. The hepatitis ...
... test before taking the cancer drug irinotecan, and the ... guidelines to say so, according to researchers at the ... also known by its brand name Camptosar, is used ... FDA recommends screening patients for a gene that could ...
Cached Biology News:Influence of sex and handedness on brain is similar in capuchin monkeys and humans 2Who will recover spontaneously from hepatitis C virus infection 2UNC study questions FDA genetic-screening guidelines for cancer drug 2
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
GOAT ANTI CARICA PAPAYA PAPAIN...
... use with T4 Polynucleotide Kinase for ... ends) of nucleic acids. In the ... the 5' phosphate group from DNA ... Gamma-phosphate of ATP to the free ...
Biology Products: